| Literature DB >> 24658096 |
Xiang-Song Wu1, Xu-An Wang1, Wen-Guang Wu1, Yun-Ping Hu1, Mao-Lan Li1, Qian Ding1, Hao Weng1, Yi-Jun Shu1, Tian-Yu Liu1, Lin Jiang1, Yang Cao1, Run-Fa Bao1, Jia-Sheng Mu1, Zhu-Jun Tan1, Feng Tao2, Ying-Bin Liu1.
Abstract
Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), a long non-coding RNA (lncRNA), is associated with metastasis and is an independent prognostic factor for lung cancer. Recent studies have demonstrated that MALAT1 plays an important role in other malignancies. However, little is known about the role of MALAT1 in gallbladder carcinoma (GBC), which is the most common cancer of the biliary tract and has an extremely poor prognosis. In this study, we focused on the expression, biological functions and mechanism of MALAT1 in GBC and found that MALAT1 was significantly upregulated in GBC tissues compared with corresponding non-cancerous tissues. Knockdown of MALAT1 in GBC cell lines using lentivirus-mediated RNA interference significantly inhibited the proliferation and metastasis of the GBC cells both in vitro and in vivo. Furthermore, ERK/MAPK pathway was found to be inactivated in the GBC cell lines after MALAT1 knockdown. These results indicated that MALAT1 might serve as an oncogenic lncRNA that promotes proliferation and metastasis of GBC and activates the ERK/MAPK pathway.Entities:
Keywords: ERK; MALAT1; MAPK; gallbladder carcinoma; lncRNA; metastasis; proliferation
Mesh:
Substances:
Year: 2014 PMID: 24658096 PMCID: PMC4049796 DOI: 10.4161/cbt.28584
Source DB: PubMed Journal: Cancer Biol Ther ISSN: 1538-4047 Impact factor: 4.742